Related Experiment Videos
Delayed lymphoid lung infiltration induced by cyclophosphamide in rats
A Lurie1, J F Bernaudin, D Theven
1Département de Pneumologie, Hôpital Cochin, Paris, France.
Summary
Cyclophosphamide (CY) lung damage is not immediate but results from delayed immune toxicity. This study reveals that CY causes lymphoid lung infiltration through a hypersensitivity reaction, not direct cellular injury.
Area of Science:
- Pulmonary toxicology
- Immunology
- Pharmacology
Background:
- Antineoplastic drugs can cause lung toxicity through direct or immune-mediated mechanisms.
- Cyclophosphamide (CY) is a commonly used antineoplastic agent with known pulmonary side effects.
Purpose of the Study:
- To investigate the mechanism of cyclophosphamide-induced pulmonary toxicity.
- To determine if CY lung damage is a direct, immediate effect or a delayed immune response.
Main Methods:
- Rats received intraperitoneal injections of cyclophosphamide (CY) or saline.
- Pulmonary and immune changes were assessed over 31 days.
- Methods included histological studies, lung water/weight ratios, and albumin transfer measurements.
Main Results:
- Lung damage was delayed, peaking at 11-14 days post-CY injection.
- Histological findings showed lymphoid infiltration and alveolitis.
- Increased pulmonary water and dry lung weight ratios were observed in CY-treated rats.
Conclusions:
- Cyclophosphamide-induced lymphoid lung infiltration is mediated by delayed immune toxicity.
- The mechanism is not a direct and immediate cytotoxic effect.
- This suggests a hypersensitivity-related pathway for CY pulmonary toxicity.